Article Text

PDF
Are B-type natriuretic peptide (BNP) and N-terminal-pro-BNP useful in neonates?
  1. Afif El-Khuffash,
  2. Eleanor J Molloy
  1. Department of Neonatology, National Maternity Hospital, Dublin, Ireland
  1. Correspondence to:
    Eleanor J Molloy
    Department of Neonatology, National Maternity Hospital, Holles St, Dublin 2, Ireland; elesean{at}hotmail.com

Abstract

B-type natriuretic peptide (BNP) and N-terminal-pro-BNP (NTpBNP) have a major role in screening and diagnosis of cardiac disease and monitoring of the treatment response in children and adults. This review discusses the evidence underpinning the potential benefits of these natriuretic peptides in neonatology. They may serve as a useful adjunct to echocardiography in the diagnosis of patent ductus arteriosus and its response to treatment and the diagnosis of persistent pulmonary hypertension of the newborn. However, more work is needed to explore the possible roles of BNP/NTpBNP in the management of sepsis and monitoring of cardiac performance in neonates.

Statistics from Altmetric.com

Footnotes

  • Competing interests: None.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.